
As it turns out, shareholders in Novo Nordisk have made a good investment.
In addition to the fact that Novo Nordisk’s share price target has gone up by 3391.96 percent since the year 2000, the company also has a habit of letting it rain by rewarding its shareholders, reports Danish business daily Børsen.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app